In the News: Lobbying for Meth Cooks
The FDA usually comes down on the side of protecting patient access, while the CDC favors greater restriction on availability.
Read MoreSelect Page
Posted by C. Scott McMillin | Apr 10, 2017 | Public Policy | 0 |
The FDA usually comes down on the side of protecting patient access, while the CDC favors greater restriction on availability.
Read MorePosted by C. Scott McMillin | Apr 6, 2017 | Thinking About Addiction | 0 |
We need the knowledge and skill to evaluate claims of effectiveness as medical treatments– for instance, to determine whether the research that supports that claim is solid, or if it’s unreliable.
Read MorePosted by C. Scott McMillin | Apr 3, 2017 | Addiction, Thinking About Addiction | 0 |
Modern healthcare, for all its spectacular innovation, still lacks a genuinely safe, effective remedy for certain types of pain.
Read MorePosted by C. Scott McMillin | Mar 30, 2017 | Addictive Substances, Thinking About Addiction | 1 |
Producers and distributors are eager to attract the higher-end customer, mostly likely an adult daily user who needs stronger pot to manage dependence on the drug.
Read MorePosted by C. Scott McMillin | Mar 27, 2017 | In the News, Public Policy | 0 |
Although polls show Americans are broadly in favor of medical marijuana, they’re not as enthusiastic about the prospect of sharing the road with seriously stoned drivers.
Read More